摘要目的 通过分析骨肉瘤复发后患者长期随访资料,探讨其转归及影响因素.方法 回顾性分析2000年6月至2012年9月国内多中心收治的72例四肢骨肉瘤复发和(或)转移患者的临床资料,男37例,女35例;年龄7～61岁,平均为22.2岁.根据肿瘤复发部位分类:股骨42例(58.3％)、胫骨18例(25％)、肱骨7例(9.7％)、腓骨5例(6.9％).根据是否合并转移分类:单纯复发14例(19.4％),复发+转移58例(80.6％):其中先复发29例(40.3％)、先转移9例(12.5％)、复发+转移20例(27.8％);14例单纯复发的患者中12例(16.7％)患者获得长期生存,2例死亡(2.8％);58例复发+转移的患者中6例长期存活(8.3％),52例死亡(72.2％).应用Kaplan-Meier方法和Log-rank检验对年龄、性别、术前、术后化疗次数及复发后治疗与否分别进行单因素分析,多因素(年龄、性别、术前、术后化疗次数及复发后治疗与否)采用Cox比例风险回归模型进行生存分析.结果 72例骨肉瘤复发患者10年总生存率为25％,Kaplan-Meier单因素分析结果显示,复发后继续接受治疗及术后化疗次数对复发后生存时间有显著影响,而年龄、性别以及术前化疗次数对复发后生存时间无明显影响.多因素Cox比例风险回归分析显示,复发后治疗继续与否以及术后化疗次数(＞3次)是影响总生存率的独立预测因素(P=0.002和P=0.007).同时根据按不同指标分组的生存曲线显示,复发后术后化疗次数对TFS无显著影响;但复发后的继续治疗对提高患者的无瘤生存率、总生存率有明显的统计学意义(P=0.026和P=0.002).结论 术后规范化疗、复发病灶的扩大切除加针对性的辅助治疗对四肢骨肉瘤患者的复发后生存时间有重要影响;进一步加强多中心合作,开展骨肉瘤复发后的多模式治疗的临床试验具有较大的临床意义.

abstractsObjective To investigate the outcome and affecting factors of patients with osteosarcoma after recurrence.Methods Retrospective analysis was used to analyze the achieved data and prognosis-related factors of 72 patients with extremity osteosarcoma after recurrence from June 2000 to September 2012 through multicenter joint treatment.37 males and 35 females were included.The overall age was 7 to 61 years old (average age22.2 years old).Classification based on the tumor recurrent parts:42 cases (58.3％) on femur,18 cases (25％) on tibia,7 cases (9.7％) on humerus and 5 cases (6.9％) on fibula.Classification based on metastases:14 cases of simple recurrence (19.4％),58 cases (80.6％) of recurrence with metastasis:29 cases (40.3％) of recurrence occurred first,9 cases (12.5％) of metastasis occurred firstly,20 cases (27.8％) of simultaneous recurrence with metastasis;12/14 patients (16.7％) of simple recurrence had long-term survival,but 2 died (2.8％).Six of 58 patients (8.3％) of recurrence with metastasis had long-term survival but 52 died (72.2％).Results The overall 10-year postrelapse survival rate of the 72 patients was 25％.Kaplan-Meier univariate analysis revealed that postrelapse survival was significantly influenced by the continued treatment after recurrence and the number of postoperative chemotherapy,but it was not significantlyinfluenced by age,gender and the number of preoperative chemotherapy.Multivariate analysis revealed that the continued treatment after recurrence and the number of postoperative chemotherapy were independent prognostic factors (P=0.002,P=0.007).At the same time,according to the survival curve grouped by different indicators,the number of chemotherapy after recurrence has no significant effect on TFS.However,the continued treatment after recurrence has obvious statistical significance on improving TFS and OS of patients (P=0.026,P=0.002).Conclusion Resection and standard postoperative chemotherapy had significant effects on the postrelapse survival in patients with osteosarcoma.There are good prospects for further multimodal therapy and multicenter cooperation for osteosarcoma after recurrence.